Test for prostate cancer ‘does more harm than good’

Men should not get a common blood test to screen for prostate cancer, according to new healthcare guidelines from Canada.

The potential for harm from prostate-specific antigen testing outweighs the benefit, says the Canadian Task Force on Preventive Health Care.

“The ratio seems to be on the harm side, not the benefit side,” said Neil Bell of the Task Force and chair of its prostate cancer screening working group.